Mixed-Methods Investigation

Fillmore has utilized mixed-methods investigation to examine the factors influencing the clinical adoption of therapeutics during the COVID-19 pandemic. His research demonstrates that the speed and scope of treatment diffusion are driven more by first-in-class status and informal communication channels, such as preprints and press releases, than by formal guideline updates. These findings suggest that early information dissemination significantly shapes provider behavior before rigorous evidence synthesis is complete.